VALENTINA SVICHER

Has grant

University of Rome Tor Vergata

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

IMmuno-VIrological DYnamics triggered by anti-HIV therapy Suspension

Open Date:

Close Date:

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Daniele Armenia

Associate Professor

Saint Camillus International University of Health Sciences

ITALY

View details

Vincenzo Esposito

Head of Immunodeficiencies and Gender related Infectious Diseases

ITALY

View details

Francesca Ceccherini-Silberstein

University of Rome Tor Vergata

ITALY

View details

ANDREA COSTANTINI

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

ITALY

View details

Velia Chiara Di Maio

University of Rome Tor Vergata

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

VALENTINA SVICHER

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers.

Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control

An increase in the levels of middle surface antigen characterizes patients developing hbv-driven liver cancer despite prolonged virological suppression

Hbcab positivity is a risk factor for an increased detectability of hiv rna after switching to a two-drug regimen lamivudine-based (2dr-3tc-based) treatment: Analysis of a multicenter italian cohort

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro

Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers

Collaborators (5)

Daniele Armenia

Vincenzo Esposito

Francesca Ceccherini-Silberstein

ANDREA COSTANTINI

Velia Chiara Di Maio

Make your next move.